
EquityEquity - OtherVery High Risk
Direct
NAV (16-Jan-26)
Returns (Since Inception)
Fund Size
₹1,615 Cr
Expense Ratio
0.56%
ISIN
INF277KA1CU2
Minimum SIP
₹1,000
Exit Load
No Charges
Inception Date
28 Nov 2024
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+1.46%
— (Cat Avg.)
Since Inception
-1.56%
— (Cat Avg.)
| Equity | ₹1,581.08 Cr | 97.91% |
| Others | ₹33.83 Cr | 2.09% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Axis Bank Ltd | Equity | ₹69.31 Cr | 4.29% |
| Tech Mahindra Ltd | Equity | ₹67.14 Cr | 4.16% |
| PB Fintech Ltd | Equity | ₹64.74 Cr | 4.01% |
| ICICI Bank Ltd | Equity | ₹64.19 Cr | 3.97% |
| Bharti Airtel Ltd | Equity | ₹60.97 Cr | 3.78% |
| Reliance Industries Ltd | Equity | ₹57.63 Cr | 3.57% |
| Adani Ports & Special Economic Zone Ltd | Equity | ₹49.07 Cr | 3.04% |
| Infosys Ltd | Equity | ₹44.54 Cr | 2.76% |
| HDFC Bank Ltd | Equity | ₹42.23 Cr | 2.61% |
| Eternal Ltd | Equity | ₹41.71 Cr | 2.58% |
| Larsen & Toubro Ltd | Equity | ₹41.45 Cr | 2.57% |
| Delhivery Ltd | Equity | ₹40.39 Cr | 2.50% |
| Hero MotoCorp Ltd | Equity | ₹37.51 Cr | 2.32% |
| Affle 3i Ltd | Equity | ₹36.7 Cr | 2.27% |
| Tata Communications Ltd | Equity | ₹36.41 Cr | 2.25% |
| Apollo Hospitals Enterprise Ltd | Equity | ₹35.9 Cr | 2.22% |
| Dr. Lal PathLabs Ltd | Equity | ₹35.66 Cr | 2.21% |
| Acutaas Chemicals Ltd | Equity | ₹33.25 Cr | 2.06% |
| eClerx Services Ltd | Equity | ₹33.08 Cr | 2.05% |
| Mahindra & Mahindra Ltd | Equity | ₹31.53 Cr | 1.95% |
| Firstsource Solutions Ltd | Equity | ₹30.84 Cr | 1.91% |
| Avenue Supermarts Ltd | Equity | ₹29.5 Cr | 1.83% |
| Metropolis Healthcare Ltd | Equity | ₹28.18 Cr | 1.75% |
| Jubilant Foodworks Ltd | Equity | ₹28.06 Cr | 1.74% |
| Maruti Suzuki India Ltd | Equity | ₹27.55 Cr | 1.71% |
| Karur Vysya Bank Ltd | Equity | ₹25.12 Cr | 1.56% |
| Vishal Mega Mart Ltd | Equity | ₹24.03 Cr | 1.49% |
| Dabur India Ltd | Equity | ₹23.92 Cr | 1.48% |
| TBO Tek Ltd | Equity | ₹23.09 Cr | 1.43% |
| ZF Commercial Vehicle Control Systems India Ltd | Equity | ₹22.92 Cr | 1.42% |
| Swiggy Ltd | Equity | ₹22.78 Cr | 1.41% |
| A) Repo | Cash - Repurchase Agreement | ₹22.62 Cr | 1.40% |
| Newgen Software Technologies Ltd | Equity | ₹20.94 Cr | 1.30% |
| RBL Bank Ltd | Equity | ₹20.84 Cr | 1.29% |
| Sonata Software Ltd | Equity | ₹20.72 Cr | 1.28% |
| Bajaj Finserv Ltd | Equity | ₹20.4 Cr | 1.26% |
| Aurobindo Pharma Ltd | Equity | ₹18.93 Cr | 1.17% |
| Thermax Ltd | Equity | ₹18.9 Cr | 1.17% |
| Syngene International Ltd | Equity | ₹18.05 Cr | 1.12% |
| Pricol Ltd | Equity | ₹17.81 Cr | 1.10% |
| PCBL Chemical Ltd | Equity | ₹17.59 Cr | 1.09% |
| Samvardhana Motherson International Ltd | Equity | ₹16.94 Cr | 1.05% |
| Craftsman Automation Ltd | Equity | ₹16.13 Cr | 1.00% |
| Wockhardt Ltd | Equity | ₹16.11 Cr | 1.00% |
| J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹15.35 Cr | 0.95% |
| HealthCare Global Enterprises Ltd | Equity | ₹14.13 Cr | 0.88% |
| Emmvee Photovoltaic Power Ltd | Equity | ₹13.3 Cr | 0.82% |
| Cohance Lifesciences Ltd | Equity | ₹11.89 Cr | 0.74% |
| Cash / Net Current Asset | Cash | ₹11.21 Cr | 0.69% |
| Neogen Chemicals Ltd | Equity | ₹11.09 Cr | 0.69% |
| Orchid Pharma Ltd | Equity | ₹10.94 Cr | 0.68% |
| Vijaya Diagnostic Centre Ltd | Equity | ₹9.97 Cr | 0.62% |
| Carborundum Universal Ltd | Equity | ₹9.88 Cr | 0.61% |
| Sona BLW Precision Forgings Ltd | Equity | ₹9.59 Cr | 0.59% |
| Akzo Nobel India Ltd | Equity | ₹7.94 Cr | 0.49% |
| Indoco Remedies Ltd | Equity | ₹7.08 Cr | 0.44% |
| Piramal Pharma Ltd | Equity | ₹6.89 Cr | 0.43% |
| PhysicsWallah Ltd | Equity | ₹6.09 Cr | 0.38% |
| Quick Heal Technologies Ltd | Equity | ₹4.98 Cr | 0.31% |
| Meesho Ltd | Equity | ₹4.06 Cr | 0.25% |
| LG Electronics India Ltd | Equity | ₹3.8 Cr | 0.24% |
| Laxmi Dental Ltd | Equity | ₹1.37 Cr | 0.08% |
Large Cap Stocks
45.91%
Mid Cap Stocks
15.35%
Small Cap Stocks
36.65%
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Consumer Cyclical | ₹323.7 Cr | 20.04% |
| Financial Services | ₹306.83 Cr | 19.00% |
| Technology | ₹239.33 Cr | 14.82% |
| Healthcare | ₹230.44 Cr | 14.27% |
| Industrials | ₹159.68 Cr | 9.89% |
| Communication Services | ₹134.08 Cr | 8.30% |
| Basic Materials | ₹69.87 Cr | 4.33% |
| Consumer Defensive | ₹59.51 Cr | 3.69% |
| Energy | ₹57.63 Cr | 3.57% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since November 2024
Since March 2025
ISIN INF277KA1CU2 | Expense Ratio 0.56% | Exit Load No Charges | Fund Size ₹1,615 Cr | Age 1 year 1 month | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty 500 TRI |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹2,23,769 Cr
Address
Mafatlal Centre, 9th Floor, Mumbai, 400 021
Your principal amount will be at Very High Risk

Download Dezerv App
Track and monitor all
your investments